$PNBK
PATRIOT NATIONAL BANCORP INC Stock $pnbk

$pnbk Overview Financials Valuation SEC Filings Company Website

2020 Q2 Form 10-Q Financial Statement

#000143774920017795 Filed on August 13, 2020

Income Statement

Concept	2020 Q2	2020 Q1	2019 Q2
Revenue	$9.603M	$10.72M	$11.09M
YoY Change	-13.44%	1.29%	12.17%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$410.0K	$392.0K	$420.0K
YoY Change	-2.38%	0.77%	7.69%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$3.916M	$4.399M	$4.474M
YoY Change	-12.47%	4.07%	57.04%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$1.724M	-$1.431M	-$2.287M
YoY Change	-24.62%	-391.45%	-261.51%
Income Tax	-$446.0K	-$359.0K	-$632.0K
% Of Pretax Income
Net Earnings	-$1.278M	-$1.072M	-$1.655M
YoY Change	-22.78%	-431.89%	-259.75%
Net Earnings / Revenue	-13.31%	-10.0%	-14.92%
Basic Earnings Per Share	-$0.32	-$0.27	-$0.42
Diluted Earnings Per Share	-$0.32	-$0.27	-$0.42
COMMON SHARES
Basic Shares Outstanding	3.935M	3.931M	3.922M
Diluted Shares Outstanding	3.935M	3.931M	3.922M

Balance Sheet

Concept	2020 Q2	2020 Q1	2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments			$99.92M
YoY Change			-12.01%
Cash & Equivalents	$65.90M	$52.16M	$51.12M
Short-Term Investments			$48.80M
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$33.96M	$34.31M	$35.25M
YoY Change	-3.65%	-2.9%	-1.3%
Goodwill	$1.107M	$1.107M	$1.107M
YoY Change	0.0%	0.0%	-47.29%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$12.20M	$12.00M	$11.10M
YoY Change	9.91%	15.38%	0.0%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$979.5M	$999.6M	$977.8M
YoY Change	0.18%	4.88%	5.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$7.700M	$8.200M	$7.700M
YoY Change	0.0%	5.13%	32.76%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$7.700M	$8.200M	$7.700M
YoY Change	0.0%	5.13%	32.76%
LONG-TERM LIABILITIES
Long-Term Debt	$30.90M	$30.90M	$30.90M
YoY Change	0.0%	-0.32%	0.0%
Other Long-Term Liabilities	$3.800M	$2.600M	$3.200M
YoY Change	18.75%	36.84%	10.34%
Total Long-Term Liabilities	$34.70M	$33.50M	$34.10M
YoY Change	1.76%	1.82%	0.89%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.700M	$8.200M	$7.700M
Total Long-Term Liabilities	$34.70M	$33.50M	$34.10M
Total Liabilities	$915.4M	$935.0M	$909.5M
YoY Change	0.65%	5.83%	5.52%
SHAREHOLDERS EQUITY
Retained Earnings	-$41.12M	-$39.85M	-$37.21M
YoY Change	10.52%	12.19%	1.09%
Common Stock	$106.3M	$106.2M	$107.2M
YoY Change	-0.92%	-0.9%	0.2%
Preferred Stock
YoY Change
Treasury Stock (at cost)			$1.179M
YoY Change			0.0%
Treasury Stock Shares			$73.74K
Shareholders Equity	$64.17M	$64.62M	$68.29M
YoY Change
Total Liabilities & Shareholders Equity	$979.5M	$999.6M	$977.8M
YoY Change	0.18%	4.88%	5.11%

Cashflow Statement

Concept	2020 Q2	2020 Q1	2019 Q2
OPERATING ACTIVITIES
Net Income	-$1.278M	-$1.072M	-$1.655M
YoY Change	-22.78%	-431.89%	-259.75%
Depreciation, Depletion And Amortization	$410.0K	$392.0K	$420.0K
YoY Change	-2.38%	0.77%	7.69%
Cash From Operating Activities	-$10.00K	-$4.313M	-$3.430M
YoY Change	-99.71%	-1091.49%	-226.57%
INVESTING ACTIVITIES
Capital Expenditures	-$120.0K	$3.000K	-$410.0K
YoY Change	-70.73%	-66.67%	-6.82%
Acquisitions
YoY Change
Other Investing Activities	$32.91M	-$5.520M	-$27.66M
YoY Change	-218.98%	-36.41%	-239.13%
Cash From Investing Activities	$32.79M	-$5.520M	-$28.06M
YoY Change	-216.86%	-36.46%	-244.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-19.04M	22.59M	25.97M
YoY Change	-173.32%	-1555.22%	1642.95%
NET CHANGE
Cash From Operating Activities	-10.00K	-4.313M	-3.430M
Cash From Investing Activities	32.79M	-5.520M	-28.06M
Cash From Financing Activities	-19.04M	22.59M	25.97M
Net Change In Cash	13.74M	12.75M	-5.520M
YoY Change	-348.91%	-230.06%	-123.35%
FREE CASH FLOW
Cash From Operating Activities	-$10.00K	-$4.313M	-$3.430M
Capital Expenditures	-$120.0K	$3.000K	-$410.0K
Free Cash Flow	$110.0K	-$4.316M	-$3.020M
YoY Change	-103.64%	-1113.15%	-195.87%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2020Q2	pnbk	Accrued Interest And Dividends Receivable AccruedInterestAndDividendsReceivable	5624000
CY2019Q4	pnbk	Accrued Interest And Dividends Receivable AccruedInterestAndDividendsReceivable	3603000
	pnbk	Amortization And Accretion Of Purchase Loan Premiums And Discounts Net AmortizationAndAccretionOfPurchaseLoanPremiumsAndDiscountsNet	-399000
	pnbk	Amortization And Accretion Of Purchase Loan Premiums And Discounts Net AmortizationAndAccretionOfPurchaseLoanPremiumsAndDiscountsNet	-463000
	pnbk	Amortization Of Servicing Assets Of Sold Loans AmortizationOfServicingAssetsOfSoldLoans	9000
	pnbk	Amortization Of Servicing Assets Of Sold Loans AmortizationOfServicingAssetsOfSoldLoans	6000
CY2020Q2	pnbk	Availableforsale Securities Debt Maturities Year One Through Five Amortized Cost Basis AvailableforsaleSecuritiesDebtMaturitiesYearOneThroughFiveAmortizedCostBasis	7447000
CY2019Q4	pnbk	Availableforsale Securities Debt Maturities Year One Through Five Amortized Cost Basis AvailableforsaleSecuritiesDebtMaturitiesYearOneThroughFiveAmortizedCostBasis	7823000
CY2020Q2	pnbk	Availableforsale Securities Debt Maturities Year One Through Five Fair Value AvailableforsaleSecuritiesDebtMaturitiesYearOneThroughFiveFairValue	7570000
CY2019Q4	pnbk	Availableforsale Securities Debt Maturities Year One Through Five Fair Value AvailableforsaleSecuritiesDebtMaturitiesYearOneThroughFiveFairValue	7961000
CY2020Q2	pnbk	Banks Reserve Based On Analysis In Unfunded Commitments BanksReserveBasedOnAnalysisInUnfundedCommitments	8000
CY2019Q4	pnbk	Banks Reserve Based On Analysis In Unfunded Commitments BanksReserveBasedOnAnalysisInUnfundedCommitments	8000
CY2020Q2	pnbk	Capital Conservation Buffer CapitalConservationBuffer	0.025
	pnbk	Capitalized Servicing Assets CapitalizedServicingAssets	29000
	pnbk	Capitalized Servicing Assets CapitalizedServicingAssets	125000
CY2020Q2	pnbk	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield Other Changes CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYieldOtherChanges
CY2019Q2	pnbk	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield Other Changes CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYieldOtherChanges	-16000
	pnbk	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield Other Changes CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYieldOtherChanges	45000
	pnbk	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield Other Changes CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYieldOtherChanges	557000
CY2020Q2	pnbk	Commitments To Extend Credit CommitmentsToExtendCredit	152376000
CY2019Q4	pnbk	Commitments To Extend Credit CommitmentsToExtendCredit	145065000
CY2020Q2	pnbk	Common Equity Tier1 Capital Required For Capital Adequacy To Risk Weighted Assets CommonEquityTier1CapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.065
CY2019Q1	pnbk	Common Equity Tier1 Capital Required For Capital Adequacy To Risk Weighted Assets CommonEquityTier1CapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.07
CY2020Q2	pnbk	Community Bank Tier One Leverage Capital Required For Capital Adequacy CommunityBankTierOneLeverageCapitalRequiredForCapitalAdequacy	10000000000
CY2020Q2	pnbk	Community Bank Tier One Leverage Ratio CommunityBankTierOneLeverageRatio	0.09
CY2020Q2	pnbk	Fees And Service Charges FeesAndServiceCharges	66000
CY2019Q2	pnbk	Fees And Service Charges FeesAndServiceCharges	116000
	pnbk	Fees And Service Charges FeesAndServiceCharges	180000
	pnbk	Fees And Service Charges FeesAndServiceCharges	243000
CY2020Q2	pnbk	Financing Receivable Principal And Interest Deferred Payments FinancingReceivablePrincipalAndInterestDeferredPayments	223200000
CY2020Q2	pnbk	Financing Receivable Troubled Debt Restructuring Number Of Contracts FinancingReceivableTroubledDebtRestructuringNumberOfContracts	9
CY2019Q4	pnbk	Financing Receivable Troubled Debt Restructuring Number Of Contracts FinancingReceivableTroubledDebtRestructuringNumberOfContracts	6
	pnbk	Gain Loss On Sale Of Sba Loans Held For Sale Net GainLossOnSaleOfSBALoansHeldForSaleNet	84000
	pnbk	Gain Loss On Sale Of Sba Loans Held For Sale Net GainLossOnSaleOfSBALoansHeldForSaleNet	676000
CY2020Q2	pnbk	General Insurance Income Expense GeneralInsuranceIncomeExpense	78000
CY2019Q2	pnbk	General Insurance Income Expense GeneralInsuranceIncomeExpense	54000
	pnbk	General Insurance Income Expense GeneralInsuranceIncomeExpense	148000
	pnbk	General Insurance Income Expense GeneralInsuranceIncomeExpense	95000
CY2020Q2	pnbk	Impaired Financing Receivable Nonperforming Loans Discount Of Appraisal Value Selling Costs Percent ImpairedFinancingReceivableNonperformingLoansDiscountOfAppraisalValueSellingCostsPercent	0.08
CY2020Q2	pnbk	Impaired Financing Receivable Nonperforming Loans Discount To Appraisal Value Percent ImpairedFinancingReceivableNonperformingLoansDiscountToAppraisalValuePercent	0.12
CY2020Q2	pnbk	Interest Expense Notes Payable InterestExpenseNotesPayable	5000
CY2019Q2	pnbk	Interest Expense Notes Payable InterestExpenseNotesPayable	8000
	pnbk	Interest Expense Notes Payable InterestExpenseNotesPayable	10000
	pnbk	Interest Expense Notes Payable InterestExpenseNotesPayable	14000
CY2020Q2	pnbk	Interest Expense Senior Debt InterestExpenseSeniorDebt	228000
CY2019Q2	pnbk	Interest Expense Senior Debt InterestExpenseSeniorDebt	228000
	pnbk	Interest Expense Senior Debt InterestExpenseSeniorDebt	457000
	pnbk	Interest Expense Senior Debt InterestExpenseSeniorDebt	457000
CY2020Q2	pnbk	Loan Application Inspection Processing Fees LoanApplicationInspectionProcessingFees	40000
CY2019Q2	pnbk	Loan Application Inspection Processing Fees LoanApplicationInspectionProcessingFees	28000
	pnbk	Loan Application Inspection Processing Fees LoanApplicationInspectionProcessingFees	93000
	pnbk	Loan Application Inspection Processing Fees LoanApplicationInspectionProcessingFees	42000
	pnbk	Loans Receivable Term To Reset To Fhlb Rate LoansReceivableTermToResetToFhlbRate	P5Y
CY2020Q2	pnbk	Loans Serviced By Entity But Owned By A Third Party LoansServicedByEntityButOwnedByAThirdParty	14900000
CY2019Q4	pnbk	Loans Serviced By Entity But Owned By A Third Party LoansServicedByEntityButOwnedByAThirdParty	13600000
CY2020Q2	pnbk	Material And Communications MaterialAndCommunications	133000
CY2019Q2	pnbk	Material And Communications MaterialAndCommunications	131000
	pnbk	Material And Communications MaterialAndCommunications	253000
	pnbk	Material And Communications MaterialAndCommunications	265000
	pnbk	Maximum Period For Charged Off Of Consumer Installment Loans MaximumPeriodForChargedOffOfConsumerInstallmentLoans	P180D
	pnbk	Maximum Period Of Credit Extension Of Construction Loans MaximumPeriodOfCreditExtensionOfConstructionLoans	P1Y180D
	pnbk	Non Cash Transactions Accrued Liability For Oreo Sale NonCashTransactionsAccruedLiabilityForOREOSale
	pnbk	Non Cash Transactions Accrued Liability For Oreo Sale NonCashTransactionsAccruedLiabilityForOREOSale	80000
	pnbk	Noncash Activity Increase In Operating Lease Liabilities NoncashActivityIncreaseInOperatingLeaseLiabilities	-57000
	pnbk	Noncash Activity Increase In Operating Lease Liabilities NoncashActivityIncreaseInOperatingLeaseLiabilities	-3424000
	pnbk	Noncash Activity Increase In Operating Lease Rightofuse Assets NoncashActivityIncreaseInOperatingLeaseRightofuseAssets	57000
	pnbk	Noncash Activity Increase In Operating Lease Rightofuse Assets NoncashActivityIncreaseInOperatingLeaseRightofuseAssets	3342000
	pnbk	Noncash Or Part Noncash Acquisition Contingent Liabilities Assumed NoncashOrPartNoncashAcquisitionContingentLiabilitiesAssumed
	pnbk	Noncash Or Part Noncash Acquisition Contingent Liabilities Assumed NoncashOrPartNoncashAcquisitionContingentLiabilitiesAssumed	621000
CY2020Q2	pnbk	Number Of Availableforsale Securities NumberOfAvailableforsaleSecurities	30
CY2019Q4	pnbk	Number Of Availableforsale Securities NumberOfAvailableforsaleSecurities	27
CY2020Q2	pnbk	Number Of Impaired Loans NumberOfImpairedLoans	30
CY2019Q4	pnbk	Number Of Impaired Loans NumberOfImpairedLoans	27
	pnbk	Payments For Origination Of Sba Loans Held For Sale PaymentsForOriginationOfSBALoansHeldForSale	2041000
	pnbk	Payments For Origination Of Sba Loans Held For Sale PaymentsForOriginationOfSBALoansHeldForSale	13077000
	pnbk	Period For Charged Off Of Closeend Credits PeriodForChargedOffOfCloseendCredits	P120D
	pnbk	Period For Charged Off Of Openend Credits PeriodForChargedOffOfOpenendCredits	P180D
	pnbk	Proceeds From Payments For Originated Loans Receivable Net ProceedsFromPaymentsForOriginatedLoansReceivableNet	55573000
	pnbk	Proceeds From Payments For Originated Loans Receivable Net ProceedsFromPaymentsForOriginatedLoansReceivableNet	-8029000
	pnbk	Proceeds From Principal Repayments On Debt Securities Available For Sale ProceedsFromPrincipalRepaymentsOnDebtSecuritiesAvailableForSale	3521000
	pnbk	Proceeds From Principal Repayments On Debt Securities Available For Sale ProceedsFromPrincipalRepaymentsOnDebtSecuritiesAvailableForSale	1422000
CY2020Q2	pnbk	Project Expenses ProjectExpenses	54000
CY2019Q2	pnbk	Project Expenses ProjectExpenses	-15000
	pnbk	Project Expenses ProjectExpenses	148000
	pnbk	Project Expenses ProjectExpenses	65000
	pnbk	Refund Of Payment For Escrow Deposit Related To Acquisition Activity RefundOfPaymentForEscrowDepositRelatedToAcquisitionActivity
	pnbk	Refund Of Payment For Escrow Deposit Related To Acquisition Activity RefundOfPaymentForEscrowDepositRelatedToAcquisitionActivity	500000
CY2020Q2	pnbk	Regulatory Assessments RegulatoryAssessments	364000
CY2019Q2	pnbk	Regulatory Assessments RegulatoryAssessments	395000
	pnbk	Regulatory Assessments RegulatoryAssessments	804000
	pnbk	Regulatory Assessments RegulatoryAssessments	710000
CY2019Q1	pnbk	Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets With Capital Buffer TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssetsWithCapitalBuffer	0.085
CY2020Q2	pnbk	Time Deposits Below Fdic Insurance Limit TimeDepositsBelowFDICInsuranceLimit	194388000
CY2019Q4	pnbk	Time Deposits Below Fdic Insurance Limit TimeDepositsBelowFDICInsuranceLimit	193942000
CY2020Q2	pnbk	Unrealized Holding Losses Depreciation Percentage From Amortized Cost UnrealizedHoldingLossesDepreciationPercentageFromAmortizedCost	0.059
CY2019Q4	pnbk	Unrealized Holding Losses Depreciation Percentage From Amortized Cost UnrealizedHoldingLossesDepreciationPercentageFromAmortizedCost	0.037
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	187000
CY2019Q1	us-gaap	Capital Required For Capital Adequacy To Risk Weighted Assets CapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.105
CY2020Q2	us-gaap	Capital Required To Be Well Capitalized To Risk Weighted Assets CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.1
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-85000
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	22000
CY2020Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-956000
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-403000
CY2020Q2	us-gaap	Advance Payments By Borrowers For Taxes And Insurance AdvancePaymentsByBorrowersForTaxesAndInsurance	3773000
CY2019Q4	us-gaap	Advance Payments By Borrowers For Taxes And Insurance AdvancePaymentsByBorrowersForTaxesAndInsurance	3681000
CY2020Q2	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	11148000
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	10115000
CY2020Q2	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	13000
CY2019Q2	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	5000
	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	54000
	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	54000
CY2020Q2	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	691000
CY2019Q2	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	2307000
	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	735000
	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	2307000
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	56000
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	56000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	37000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	37000
CY2020Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	15857
CY2019Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5572
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4165
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3005
CY2020Q2	us-gaap	Assets Assets	979544000
CY2019Q4	us-gaap	Assets Assets	979836000
CY2020Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	412000
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	405000
CY2020Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1701000
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	948000
CY2020Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	47913000
CY2019Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	48860000
CY2020Q2	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	29430000
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	30226000
CY2020Q2	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	27883000
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	29497000
CY2020Q2	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	11036000
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	10811000
CY2020Q2	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	11171000
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	10859000
CY2020Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	46624000
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	48317000
	us-gaap	Basis Of Accounting BasisOfAccounting	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font: inherit;">1.</div>     Basis of Financial Statement Presentation</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The accompanying unaudited condensed consolidated financial statements of Patriot National Bancorp, Inc. (the “Company”) and its wholly-owned subsidiaries Patriot Bank, N.A. (the “Bank”) , Patriot National Statutory Trust I and PinPat Acquisition Corporation (collectively, “Patriot”), have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) have been omitted. The accompanying unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included on the Annual Report on Form <div style="display: inline; font-style: italic; font: inherit;">10</div>-K for the year ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2019.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The consolidated balance sheet at <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2019 </div>presented herein has been derived from the audited consolidated financial statements of the Company at that date, but does <div style="display: inline; font-style: italic; font: inherit;">not</div> include all of the information and footnotes required by US GAAP for complete financial statements.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The preparation of consolidated financial statements in accordance with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and to disclose contingent assets and liabilities. Actual results could differ from those estimates. Management has identified accounting for the allowance for loan and lease losses, the analysis and valuation of its investment securities, the valuation of deferred tax assets, the impairment of goodwill, the valuation of derivatives, and the valuation of servicing assets as certain of the Company's more significant accounting policies and estimates, in that they are critical to the presentation of the Company's consolidated financial condition and results of operations. As they concern matters that are inherently uncertain, these estimates require management to make subjective and complex judgments in the preparation of the Company's consolidated financial statements.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; text-decoration: underline;">Reclassifications:</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Certain amounts appearing in the financial statements and notes thereto for prior periods have been reclassified to conform with the current presentation. The reclassifications had <div style="display: inline; font-style: italic; font: inherit;">no</div> effect on net income or stockholders' equity as previously reported.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The information furnished reflects, in the opinion of management, all normal recurring adjustments necessary for a fair presentation of the results for the interim periods presented. The results of operations for the <div style="display: inline; font-style: italic; font: inherit;">three</div> and <div style="display: inline; font-style: italic; font: inherit;">six</div> months ended <div style="display: inline; font-style: italic; font: inherit;"> June 30, 2020 </div>are <div style="display: inline; font-style: italic; font: inherit;">not</div> necessarily indicative of the results of operations that <div style="display: inline; font-style: italic; font: inherit;"> may </div>be expected for the remainder of <div style="display: inline; font-style: italic; font: inherit;">2020.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; text-decoration: underline;">COVID-<div style="display: inline; font-style: italic; font: inherit;">19</div> Impact</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In <div style="display: inline; font-style: italic; font: inherit;"> March 2020, </div>the World Health Organization declared novel coronavirus disease <div style="display: inline; font-style: italic; font: inherit;">2019</div> ("COVID-<div style="display: inline; font-style: italic; font: inherit;">19"</div>) as a global pandemic. The COVID-<div style="display: inline; font-style: italic; font: inherit;">19</div> pandemic has negatively impacted the global and U.S. economies. Many businesses in the U.S., including those in the markets we serve, were required to close, causing a significant increase in unemployment and loss of revenue for businesses that were required to close.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The consolidated financial statements reflect estimates and assumptions that affect the reported amounts of assets and liabilities, including the amount of the allowance for loan losses. The assumptions and estimates used in the financial statements were impacted by the COVID-<div style="display: inline; font-style: italic; font: inherit;">19</div> pandemic. The COVID-<div style="display: inline; font-style: italic; font: inherit;">19</div> pandemic did have an adverse impact on our earnings and resulted in an increase to the provision for loan losses when compared to the same period in <div style="display: inline; font-style: italic; font: inherit;">2019.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">We are unable to estimate the full impact of COVID-<div style="display: inline; font-style: italic; font: inherit;">19</div> on our business and operations at this time. The extent of such impact will depend on future developments, which are highly uncertain, including when COVID-<div style="display: inline; font-style: italic; font: inherit;">19</div> can be controlled and abated and when and how the economy <div style="display: inline; font-style: italic; font: inherit;"> may </div>be reopened. The pandemic could cause us to experience higher credit losses in our loan portfolio, impairment of our goodwill, reduced demand for our products and services, or other negative impacts on our financial position, results of operations, and prospects.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">On <div style="display: inline; font-style: italic; font: inherit;"> March 27, 2020, </div>the President of the United States signed into law the Coronavirus Aid, Relief and Economic Security (“CARES”) Act in response to the coronavirus pandemic. This legislation aims at providing relief for individuals and businesses that have been negatively impacted by the coronavirus pandemic.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The CARES Act includes a provision for the Company to opt out of applying the “troubled-debt restructuring” (“TDR”) accounting guidance in ASC <div style="display: inline; font-style: italic; font: inherit;">310</div>-<div style="display: inline; font-style: italic; font: inherit;">40</div> for certain loan modifications. Loan modifications made between <div style="display: inline; font-style: italic; font: inherit;"> March 1, 2020 </div>and the earlier of i) <div style="display: inline; font-style: italic; font: inherit;"> December 30, 2020 </div>or ii) <div style="display: inline; font-style: italic; font: inherit;">60</div> days after the President declares a termination of the COVID-<div style="display: inline; font-style: italic; font: inherit;">19</div> national emergency are eligible for this relief if the related loans were <div style="display: inline; font-style: italic; font: inherit;">not</div> more than <div style="display: inline; font-style: italic; font: inherit;">30</div> days past due as of <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2019. </div>The Company has assessed which loans qualify for this treatment. The CARES Act also permits the Bank to continue to accrue interest on loans that have received deferral treatment as a result of the pandemic. In addition, on <div style="display: inline; font-style: italic; font: inherit;"> April 7, 2020, </div>a group of banking regulatory agencies issued a revised interagency statement that offers practical expedients for evaluating whether COVID-<div style="display: inline; font-style: italic; font: inherit;">19</div> loan modifications are TDRs.</div></div>
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	50000
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	65896000
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39404000
CY2020Q2	us-gaap	Cash And Due From Banks CashAndDueFromBanks	1616000
CY2019Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	2693000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	39404000
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	66437000
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	65896000
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	51116000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	26492000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-15321000
CY2020Q1	us-gaap	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYield
CY2019Q1	us-gaap	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYield	194000
CY2019Q4	us-gaap	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYield	47000
CY2018Q4	us-gaap	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYield	792000
CY2020Q2	us-gaap	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYield
CY2019Q2	us-gaap	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYield	201000
CY2020Q2	us-gaap	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield Accretion CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYieldAccretion
CY2019Q2	us-gaap	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield Accretion CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYieldAccretion	9000
	us-gaap	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield Accretion CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYieldAccretion	2000
	us-gaap	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield Accretion CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYieldAccretion	34000
CY2020Q2	us-gaap	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Carrying Amount Net CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesCarryingAmountNet	0
CY2019Q4	us-gaap	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Carrying Amount Net CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesCarryingAmountNet	176000
CY2020Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.01
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.01
CY2020Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2020Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4009582
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4004410
CY2020Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3935841
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3930669
CY2020Q2	us-gaap	Common Stock Value CommonStockValue	106251000
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	106170000
CY2020Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-489000
CY2019Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1376000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2903000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1065000
CY2020Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	14243000
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	17081000
CY2020Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	1303000
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	886000
CY2020Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	12904000
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	7724000
CY2020Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	398000
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	62000
CY2020Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	27147000
CY2019Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	24805000
CY2020Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	1701000
CY2019Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	948000
CY2020Q2	us-gaap	Deteriorated Loans Transferred In Debt Securities Accreditable Yield Period Increase Decrease DeterioratedLoansTransferredInDebtSecuritiesAccreditableYieldPeriodIncreaseDecrease	0
	us-gaap	Deteriorated Loans Transferred In Debt Securities Accreditable Yield Period Increase Decrease DeterioratedLoansTransferredInDebtSecuritiesAccreditableYieldPeriodIncreaseDecrease	2000
CY2019Q2	us-gaap	Deteriorated Loans Transferred In Debt Securities Accreditable Yield Period Increase Decrease DeterioratedLoansTransferredInDebtSecuritiesAccreditableYieldPeriodIncreaseDecrease	9000
	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	545000
CY2020Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	18
CY2019Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	15
CY2020Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	12180000
CY2019Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	11133000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-854000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-361000
CY2020Q2	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	62000
	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	151000
CY2019Q2	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	88000
	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	142000
	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.5
	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.06
CY2020Q2	us-gaap	Deposits Deposits	783088000
CY2019Q4	us-gaap	Deposits Deposits	769535000
CY2020Q2	us-gaap	Deposits Domestic DepositsDomestic	783088000
CY2019Q4	us-gaap	Deposits Domestic DepositsDomestic	769535000
CY2020Q2	us-gaap	Deposits Money Market Deposits DepositsMoneyMarketDeposits	165658000
CY2019Q4	us-gaap	Deposits Money Market Deposits DepositsMoneyMarketDeposits	99115000
CY2020Q2	us-gaap	Deposits Negotiable Order Of Withdrawal Now DepositsNegotiableOrderOfWithdrawalNOW	26941000
CY2019Q4	us-gaap	Deposits Negotiable Order Of Withdrawal Now DepositsNegotiableOrderOfWithdrawalNOW	26864000
CY2020Q2	us-gaap	Deposits Savings Deposits DepositsSavingsDeposits	70230000
CY2019Q4	us-gaap	Deposits Savings Deposits DepositsSavingsDeposits	64020000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	778000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	790000
CY2020Q2	us-gaap	Derivative Assets DerivativeAssets	1359000
CY2019Q4	us-gaap	Derivative Assets DerivativeAssets	694000
	us-gaap	Deteriorated Loans Transferred In Debt Securities Accreditable Yield Period Increase Decrease DeterioratedLoansTransferredInDebtSecuritiesAccreditableYieldPeriodIncreaseDecrease	34000
CY2020Q2	us-gaap	Dividend Income Operating DividendIncomeOperating	90000
CY2019Q2	us-gaap	Dividend Income Operating DividendIncomeOperating	114000
	us-gaap	Dividend Income Operating DividendIncomeOperating	228000
	us-gaap	Dividend Income Operating DividendIncomeOperating	232000
CY2019Q2	us-gaap	Dividends Common Stock DividendsCommonStock	38000
	us-gaap	Dividends Common Stock DividendsCommonStock	77000
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.42
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.60
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
CY2019Q2	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	212000
	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	118000
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.42
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.60
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.34
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	50000
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	187000
CY2020Q2	us-gaap	Federal Home Loan Bank Advances Long Term FederalHomeLoanBankAdvancesLongTerm	90000000
CY2019Q4	us-gaap	Federal Home Loan Bank Advances Long Term FederalHomeLoanBankAdvancesLongTerm	100000000
CY2020Q2	us-gaap	Federal Home Loan Bank Stock FederalHomeLoanBankStock	4503000
CY2019Q4	us-gaap	Federal Home Loan Bank Stock FederalHomeLoanBankStock	4477000
CY2020Q2	us-gaap	Federal Reserve Bank Stock FederalReserveBankStock	2897000
CY2019Q4	us-gaap	Federal Reserve Bank Stock FederalReserveBankStock	2897000
CY2020Q2	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	3
CY2019Q2	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	1
	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	3
	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	2
CY2020Q2	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2	177000
CY2019Q2	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2	111000
	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2	177000
	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2	8911000
CY2020Q2	us-gaap	Financing Receivable Modifications Pre Modification Recorded Investment2 FinancingReceivableModificationsPreModificationRecordedInvestment2	178000
CY2019Q2	us-gaap	Financing Receivable Modifications Pre Modification Recorded Investment2 FinancingReceivableModificationsPreModificationRecordedInvestment2	112000
	us-gaap	Financing Receivable Modifications Pre Modification Recorded Investment2 FinancingReceivableModificationsPreModificationRecordedInvestment2	178000
	us-gaap	Financing Receivable Modifications Pre Modification Recorded Investment2 FinancingReceivableModificationsPreModificationRecordedInvestment2	8912000
CY2020Q2	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	11120000
CY2019Q4	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	10953000
CY2020Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	586000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	623000
CY2020Q2	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	72000
CY2019Q2	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	296000
	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	84000
	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	676000
	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate
	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	-14000
CY2020Q1	us-gaap	Goodwill Goodwill	1107000
CY2019Q1	us-gaap	Goodwill Goodwill	1107000
CY2019Q4	us-gaap	Goodwill Goodwill	1107000
CY2018Q4	us-gaap	Goodwill Goodwill	1728000
CY2020Q2	us-gaap	Goodwill Goodwill	1107000
CY2019Q2	us-gaap	Goodwill Goodwill	1107000
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2020Q2	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments
CY2019Q2	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments
	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments
	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-621000
CY2020Q2	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	21967000
CY2019Q2	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	26321000
	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	20758000
	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	24600000
CY2020Q2	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	73000
CY2019Q4	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	19600000
CY2020Q2	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	1600000
CY2020Q2	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	23200000
CY2019Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	1500000
CY2020Q2	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	12958000
CY2019Q2	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	22105000
	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	11835000
	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	19224000
CY2020Q2	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod	37000
CY2019Q2	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod	212000
	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod	78000
	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod	545000
CY2020Q2	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	9009000
CY2019Q2	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	4216000
	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	8923000
	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	5376000
CY2020Q2	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	36000
CY2019Q2	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	40000
	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1724000
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-2287000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-3155000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1796000
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-446000
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-632000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-805000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-464000
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-196000
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	22000
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-1618000
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-275000
	us-gaap	Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance	92000
	us-gaap	Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance	313000
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	13553000
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	24285000
	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	2021000
	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	-88000
	us-gaap	Increase Decrease In Loans From Other Federal Home Loan Banks IncreaseDecreaseInLoansFromOtherFederalHomeLoanBanks	-10000000
	us-gaap	Increase Decrease In Loans From Other Federal Home Loan Banks IncreaseDecreaseInLoansFromOtherFederalHomeLoanBanks
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	342000
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1379000
CY2020Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
CY2019Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
CY2020Q2	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	371000
CY2019Q2	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	361000
	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	761000
	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	731000
CY2020Q2	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	9603000
CY2019Q2	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	11094000
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	20325000
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	21679000
CY2020Q2	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	9111000
CY2019Q2	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	10345000
	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	19144000
	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	20100000
CY2020Q2	us-gaap	Interest Bearing Deposit Liabilities InterestBearingDepositLiabilities	685728000
CY2019Q4	us-gaap	Interest Bearing Deposit Liabilities InterestBearingDepositLiabilities	681400000
CY2020Q2	us-gaap	Interest Bearing Deposit Liabilities Domestic InterestBearingDepositLiabilitiesDomestic	685728000
CY2019Q4	us-gaap	Interest Bearing Deposit Liabilities Domestic InterestBearingDepositLiabilitiesDomestic	681400000
CY2020Q2	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	64280000
CY2019Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	36711000
CY2020Q2	us-gaap	Interest Bearing Domestic Deposit Brokered InterestBearingDomesticDepositBrokered	160885000
CY2019Q4	us-gaap	Interest Bearing Domestic Deposit Brokered InterestBearingDomesticDepositBrokered	229909000
CY2020Q2	us-gaap	Interest Expense InterestExpense	3916000
CY2019Q2	us-gaap	Interest Expense InterestExpense	4474000
	us-gaap	Interest Expense InterestExpense	8315000
	us-gaap	Interest Expense InterestExpense	8701000
CY2020Q2	us-gaap	Interest Expense Deposits InterestExpenseDeposits	2792000
CY2019Q2	us-gaap	Interest Expense Deposits InterestExpenseDeposits	3533000
	us-gaap	Interest Expense Deposits InterestExpenseDeposits	5992000
	us-gaap	Interest Expense Deposits InterestExpenseDeposits	6797000
CY2020Q2	us-gaap	Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm	638000
CY2019Q2	us-gaap	Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm	426000
	us-gaap	Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm	1335000
	us-gaap	Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm	865000
CY2020Q2	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures	253000
CY2019Q2	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures	279000
	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures	521000
	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures	568000
CY2020Q2	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	4777000
CY2019Q2	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	3683000
	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	10296000
	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	9876000
CY2020Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	5687000
CY2019Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	6620000
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	12010000
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	12978000
CY2020Q2	us-gaap	Interest Income Operating InterestIncomeOperating	378000
CY2019Q2	us-gaap	Interest Income Operating InterestIncomeOperating	398000
	us-gaap	Interest Income Operating InterestIncomeOperating	794000
	us-gaap	Interest Income Operating InterestIncomeOperating	777000
CY2020Q2	us-gaap	Interest Income Other Domestic Deposits InterestIncomeOtherDomesticDeposits	24000
CY2019Q2	us-gaap	Interest Income Other Domestic Deposits InterestIncomeOtherDomesticDeposits	237000
	us-gaap	Interest Income Other Domestic Deposits InterestIncomeOtherDomesticDeposits	159000
	us-gaap	Interest Income Other Domestic Deposits InterestIncomeOtherDomesticDeposits	570000
	us-gaap	Interest Paid Net InterestPaidNet	9058000
	us-gaap	Interest Paid Net InterestPaidNet	8761000
CY2020Q2	us-gaap	Investments Investments	51074000
CY2019Q4	us-gaap	Investments Investments	52767000
CY2020Q2	us-gaap	Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust	8106000
CY2019Q4	us-gaap	Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust	8102000
CY2020Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	3645000
CY2019Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	3608000
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	7506000
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	6792000
CY2020Q2	us-gaap	Liabilities Liabilities	915372000
CY2019Q4	us-gaap	Liabilities Liabilities	912842000
CY2020Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	979544000
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	979836000
CY2020Q2	us-gaap	Loan Processing Fee LoanProcessingFee	36000
CY2019Q2	us-gaap	Loan Processing Fee LoanProcessingFee	43000
	us-gaap	Loan Processing Fee LoanProcessingFee	60000
	us-gaap	Loan Processing Fee LoanProcessingFee	57000
CY2020Q1	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	10916000
CY2020Q2	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	11148000
CY2019Q1	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	7823000
CY2019Q2	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	8458000
CY2019Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	10115000
CY2018Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	7609000
CY2020Q2	us-gaap	Loans And Leases Receivable Impaired Commitment To Lend LoansAndLeasesReceivableImpairedCommitmentToLend	0
CY2019Q4	us-gaap	Loans And Leases Receivable Impaired Commitment To Lend LoansAndLeasesReceivableImpairedCommitmentToLend	0
CY2020Q2	us-gaap	Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans	284000
	us-gaap	Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans	475000
CY2019Q2	us-gaap	Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans	132000
	us-gaap	Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans	371000
CY2020Q2	us-gaap	Loans Receivable Held For Sale Amount LoansReceivableHeldForSaleAmount	7579000
CY2019Q4	us-gaap	Loans Receivable Held For Sale Amount LoansReceivableHeldForSaleAmount	15282000
CY2020Q2	us-gaap	Loans Receivable Held For Sale Net Not Part Of Disposal Group LoansReceivableHeldForSaleNetNotPartOfDisposalGroup	7600000
CY2019Q4	us-gaap	Loans Receivable Held For Sale Net Not Part Of Disposal Group LoansReceivableHeldForSaleNetNotPartOfDisposalGroup	15300000
CY2020Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	123000
CY2019Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	77000
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	270000
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	192000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3546000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	24424000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	27270000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-36752000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4324000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2993000
	us-gaap	Net Income Loss NetIncomeLoss	-2350000
	us-gaap	Net Income Loss NetIncomeLoss	-1332000
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-1278000
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-1655000
CY2020Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1278000
CY2019Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1655000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2350000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1332000
CY2020Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-1278000
CY2019Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-1655000
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-2350000
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-1332000
CY2020Q2	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	97360000
CY2019Q4	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	88135000
CY2020Q2	us-gaap	Noninterest Bearing Deposit Liabilities Domestic NoninterestBearingDepositLiabilitiesDomestic	97360000
CY2019Q4	us-gaap	Noninterest Bearing Deposit Liabilities Domestic NoninterestBearingDepositLiabilitiesDomestic	88135000
CY2020Q2	us-gaap	Noninterest Expense NoninterestExpense	6890000
	us-gaap	Noninterest Income NoninterestIncome	810000
CY2019Q2	us-gaap	Noninterest Expense NoninterestExpense	6728000
	us-gaap	Noninterest Expense NoninterestExpense	14261000
	us-gaap	Noninterest Expense NoninterestExpense	13176000
CY2020Q2	us-gaap	Noninterest Income NoninterestIncome	389000
CY2019Q2	us-gaap	Noninterest Income NoninterestIncome	758000
	us-gaap	Noninterest Income NoninterestIncome	1504000
CY2020Q2	us-gaap	Noninterest Income Other NoninterestIncomeOther	80000
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	931000
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	1096000
CY2020Q2	us-gaap	Other Investments OtherInvestments	4450000
CY2019Q4	us-gaap	Other Investments OtherInvestments	4450000
CY2020Q2	us-gaap	Other Real Estate OtherRealEstate	2400000
CY2019Q4	us-gaap	Other Real Estate OtherRealEstate	2400000
	us-gaap	Other Than Temporary Impairment Loss Debt Securities Available For Sale OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale	0
	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0
	us-gaap	Payments For Proceeds From Federal Home Loan Bank Stock PaymentsForProceedsFromFederalHomeLoanBankStock	26000
CY2019Q2	us-gaap	Noninterest Income Other NoninterestIncomeOther	126000
	us-gaap	Noninterest Income Other NoninterestIncomeOther	191000
	us-gaap	Noninterest Income Other NoninterestIncomeOther	221000
CY2020Q2	us-gaap	Notes Payable To Bank NotesPayableToBank	1094000
CY2019Q4	us-gaap	Notes Payable To Bank NotesPayableToBank	1193000
CY2020Q2	us-gaap	Notes Receivable Net NotesReceivableNet	781352000
CY2019Q4	us-gaap	Notes Receivable Net NotesReceivableNet	802049000
CY2020Q2	us-gaap	Occupancy Net OccupancyNet	921000
CY2019Q2	us-gaap	Occupancy Net OccupancyNet	744000
	us-gaap	Occupancy Net OccupancyNet	1870000
	us-gaap	Occupancy Net OccupancyNet	1661000
CY2020Q2	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	131000
CY2019Q2	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	192000
	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	262000
	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	322000
CY2020Q2	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	7654000
CY2019Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	8726000
CY2020Q2	us-gaap	Other Assets OtherAssets	10384000
CY2019Q4	us-gaap	Other Assets OtherAssets	9526000
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	789000
CY2019Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	279000
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-553000
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	267000
CY2020Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	1062000
CY2019Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	362000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-746000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	347000
CY2020Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	273000
CY2019Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	83000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-193000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	80000
CY2020Q2	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	439000
CY2019Q2	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	527000
	us-gaap	Payments For Proceeds From Federal Home Loan Bank Stock PaymentsForProceedsFromFederalHomeLoanBankStock	-415000
	us-gaap	Payments For Proceeds From Federal Reserve Bank Stock PaymentsForProceedsFromFederalReserveBankStock
	us-gaap	Payments For Proceeds From Federal Reserve Bank Stock PaymentsForProceedsFromFederalReserveBankStock	56000
CY2019Q2	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	38000
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	77000
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	2659000
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	5396000
	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	29017000
	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	26088000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	122000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	417000
CY2020Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2020Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2020Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2020Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2020Q2	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0
	us-gaap	Proceeds From Sale Of Other Loans Held For Sale ProceedsFromSaleOfOtherLoansHeldForSale	1827000
	us-gaap	Proceeds From Sale Of Other Loans Held For Sale ProceedsFromSaleOfOtherLoansHeldForSale	9470000
	us-gaap	Proceeds From Sale Of Other Real Estate ProceedsFromSaleOfOtherRealEstate
	us-gaap	Proceeds From Sale Of Other Real Estate ProceedsFromSaleOfOtherRealEstate	897000
CY2020Q2	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	726000
CY2019Q2	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	803000
	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	1510000
	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	1512000
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	33962000
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	34568000
CY2020Q2	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	910000
CY2019Q2	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	2937000
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	1714000
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	3102000
	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	1714000
	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	3102000
CY2020Q2	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	910000
CY2019Q2	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	2937000
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	99000
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	97000
CY2020Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-41123000
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-38773000
CY2020Q2	us-gaap	Senior Notes SeniorNotes	11890000
CY2019Q4	us-gaap	Senior Notes SeniorNotes	11853000
CY2020Q2	us-gaap	Servicing Asset ServicingAsset	221000
CY2020Q1	us-gaap	Servicing Asset At Amortized Value ServicingAssetAtAmortizedValue	198000
CY2019Q1	us-gaap	Servicing Asset At Amortized Value ServicingAssetAtAmortizedValue	99000
CY2019Q4	us-gaap	Servicing Asset At Amortized Value ServicingAssetAtAmortizedValue	201000
CY2018Q4	us-gaap	Servicing Asset At Amortized Value ServicingAssetAtAmortizedValue	37000
CY2020Q2	us-gaap	Servicing Asset At Amortized Value ServicingAssetAtAmortizedValue	221000
CY2019Q2	us-gaap	Servicing Asset At Amortized Value ServicingAssetAtAmortizedValue	156000
CY2020Q2	us-gaap	Servicing Asset At Amortized Value Additions ServicingAssetAtAmortizedValueAdditions	27000
CY2019Q2	us-gaap	Servicing Asset At Amortized Value Additions ServicingAssetAtAmortizedValueAdditions	60000
	us-gaap	Servicing Asset At Amortized Value Additions ServicingAssetAtAmortizedValueAdditions	29000
	us-gaap	Servicing Asset At Amortized Value Additions ServicingAssetAtAmortizedValueAdditions	125000
CY2020Q2	us-gaap	Servicing Asset At Amortized Value Amortization1 ServicingAssetAtAmortizedValueAmortization1	4000
CY2019Q2	us-gaap	Servicing Asset At Amortized Value Amortization1 ServicingAssetAtAmortizedValueAmortization1	3000
	us-gaap	Servicing Asset At Amortized Value Amortization1 ServicingAssetAtAmortizedValueAmortization1	9000
	us-gaap	Servicing Asset At Amortized Value Amortization1 ServicingAssetAtAmortizedValueAmortization1	6000
CY2020Q2	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	283000
	us-gaap	Share Based Compensation ShareBasedCompensation	81000
	us-gaap	Share Based Compensation ShareBasedCompensation	103000
CY2020Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	38000
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	81000
CY2019Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	55000
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	103000
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	64172000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	66994000
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	64623000
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	69649000
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	68290000
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	69340000
CY2020Q2	us-gaap	Subordinated Debt SubordinatedDebt	9767000
CY2019Q4	us-gaap	Subordinated Debt SubordinatedDebt	9752000
CY2020Q2	us-gaap	Tier One Leverage Capital Required To Be Well Capitalized To Average Assets TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets	0.09
CY2020Q2	us-gaap	Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.08
CY2020Q2	us-gaap	Time Deposit Maturities Remainder Of Fiscal Year TimeDepositMaturitiesRemainderOfFiscalYear	390862000
CY2020Q2	us-gaap	Time Deposit Maturities Year Four TimeDepositMaturitiesYearFour	868000
CY2020Q2	us-gaap	Time Deposit Maturities Year One TimeDepositMaturitiesYearOne	26780000
CY2020Q2	us-gaap	Time Deposit Maturities Year Three TimeDepositMaturitiesYearThree	1151000
CY2020Q2	us-gaap	Time Deposit Maturities Year Two TimeDepositMaturitiesYearTwo	3238000
CY2020Q2	us-gaap	Time Deposits TimeDeposits	422899000
CY2020Q2	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	67626000
CY2019Q4	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	67550000
	us-gaap	Transfer Of Loans Held For Sale To Portfolio Loans1 TransferOfLoansHeldForSaleToPortfolioLoans1	8001000
	us-gaap	Transfer Of Loans Held For Sale To Portfolio Loans1 TransferOfLoansHeldForSaleToPortfolioLoans1
	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	8000000
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3935109
CY2019Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3921878
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3933249
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3919608
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3935109
CY2019Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3921878
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3933249
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3919608

Files In Submission

Name	View Source	Status
0001437749-20-017795-index-headers.html	Edgar Link	pending
0001437749-20-017795-index.html	Edgar Link	pending
0001437749-20-017795.txt	Edgar Link	pending
0001437749-20-017795-xbrl.zip	Edgar Link	pending
ex_198323.htm	Edgar Link	pending
ex_198324.htm	Edgar Link	pending
ex_198325.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
pnbk-20200630.xml	Edgar Link	completed
pnbk-20200630.xsd	Edgar Link	pending
pnbk-20200630_cal.xml	Edgar Link	unprocessable
pnbk-20200630_def.xml	Edgar Link	unprocessable
pnbk-20200630_lab.xml	Edgar Link	unprocessable
pnbk-20200630_pre.xml	Edgar Link	unprocessable
pnbk20200630_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PNBK
PATRIOT NATIONAL BANCORP INC Stock $pnbk

2020 Q2 Form 10-Q Financial Statement

#000143774920017795 Filed on August 13, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PNBK PATRIOT NATIONAL BANCORP INC Stock $pnbk

2020 Q2 Form 10-Q Financial Statement

#000143774920017795 Filed on August 13, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PNBK
PATRIOT NATIONAL BANCORP INC Stock $pnbk